Related Experiment Video
Updated: Jul 17, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Lung adenocarcinoma with micropapillary and solid patterns: Recurrence rate and trends
Naoki Takeno1, Shintaro Tarumi1, Masahiro Abe1
1Department of Thoracic Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan.
Lung adenocarcinoma with micropapillary (MP) or solid pattern (SP) shows higher recurrence rates. Preventing distant metastases is crucial for improving outcomes in these patients.
Area of Science:
- Oncology
- Thoracic Surgery
- Pathology
Background:
- Lung adenocarcinoma with micropapillary pattern (MP) or solid pattern (SP) is associated with poor prognosis and frequent recurrence.
- Established treatment strategies for these specific histological subtypes are lacking.
- This study investigates recurrence patterns and rates in lung adenocarcinoma patients with MP or SP.
Purpose of the Study:
- To compare recurrence rates and patterns between lung adenocarcinoma patients with and without micropapillary (MP) or solid pattern (SP).
- To identify prognostic factors associated with recurrence in these histological subtypes.
- To inform potential treatment strategies for early-stage lung adenocarcinoma with MP or SP.
Main Methods:
- Retrospective analysis of 238 lung adenocarcinoma patients undergoing radical resection.
- Classification into three groups: neither MP nor SP (MP-/SP-), MP (MP+), and SP (SP+).
- Evaluation of clinical/pathological characteristics, recurrence-free survival (RFS), recurrence sites, PD-L1 expression, and driver mutations.
Main Results:
- Significantly higher recurrence rates and shorter RFS were observed in MP+ and SP+ groups compared to MP-/SP-.
- Micropapillary pattern (MP) was an independent predictor of recurrence in multivariate analysis.
- Distant metastases were the predominant recurrence pattern in MP+ and SP+ groups; PD-L1 was highly expressed in recurrent SP+ cases.
Conclusions:
- Early-stage lung adenocarcinoma with MP or SP exhibits a high risk of postoperative recurrence.
- Focusing on the prevention of distant metastases is critical for improving patient prognosis.
- Consideration of aggressive postoperative chemotherapy may be warranted for patients with these histological subtypes.
More Related Videos
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
05:23Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
Published on: July 7, 2023